Press Releases

GlobeNewswire, Inc.

MONTREAL, Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to supporting scientific projects that explore the microbiome, is inviting grant applications from researchers...

EIN Presswire

Shmush!

EIN Presswire

TEMECULA , CA, UNITED STATES, October 2, 2026 /⁨EINPresswire.com⁩/ -- Neuroscientist and biochemical researcher Dr. Dayan Goodenowe announced the approval of a large epidemiological tracking trial designed to evaluate the associations between...

GlobeNewswire, Inc.

Patent expands protection for catheter-based technologies enabling transvascular access, treatment guidance, adaptive treatment delivery, and real-time procedural validation beyond the lumen wall Patent reinforces Autonomix’s transvascular...

GlobeNewswire, Inc.

TORONTO and HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune...

Government of Saskatchewan

CANADA, October 1 - Released on October 1, 2026 More than 500 people are working on the 300 MW data centre site in the Rural Municipality (RM) of Sherwood, with all four building shells taking shape and more than 30 local firms supporting the...

GlobeNewswire, Inc.

Markham, ON, Canada, Oct. 01, 2026 (GLOBE NEWSWIRE) -- This October, Children Believe is asking Canadians to Carry the Weight by inviting them to join a month-long walking challenge built to lighten that load for kids around the world....

GlobeNewswire, Inc.

NEW YORK, NY, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Partnership brings FINTECH.TV’s 24/7 financial news channel into short-term rentals and boutique hotels, extending live market coverage beyond the traditional home FINTECH.TV, the global financial...

GlobeNewswire, Inc.

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- As humanity explores beyond Earth, long-lasting, reliable power is essential.

GlobeNewswire, Inc.

Lakeland, FL, USA, Oct. 01, 2026 (GLOBE NEWSWIRE) -- CartiVex today outlined the formula behind the CartiVex supplement, a once-daily joint support capsule developed for adults who want to add a simple, consistent step to their everyday joint...

GlobeNewswire, Inc.

Same specialty expertise.

GlobeNewswire, Inc.

Quito, Ecuador, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Quito is strengthening its connectivity with North America through new direct Air Canada flights, creating additional opportunities for travelers from Canada and the United States to access...

GlobeNewswire, Inc.

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Canada says it will be barrier-free for members of the disability community by 2040. Will it? And what does barrier-free mean?

GlobeNewswire, Inc.

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- As Canada’s inflammatory bowel disease (IBD) population continues to grow, Crohn’s and Colitis Canada is committed to invest 1.5 million over three years across four research projects aimed at advancing...

GlobeNewswire, Inc.

CALGARY, ALBERTA, Oct. 01, 2026 (GLOBE NEWSWIRE) -- To kick-off Mental Health Awareness Month in October, BASF Agricultural Solutions Canada (BASF) and The Do More Agriculture Foundation (Do More Ag) are encouraging Canada’s agriculture community...

GlobeNewswire, Inc.

PolyPid Submitted Marketing Authorization Application to European Medicines Agency for D-PLEX₁₀₀ Last month Validation confirms that the application is complete and EMA initiates formal review of D-PLEX₁₀₀ D-PLEX₁₀₀ NDA concurrently under FDA...

GlobeNewswire, Inc.

Ottawa, Oct. 01, 2026 (GLOBE NEWSWIRE) -- At a moment when Canadians are rallying behind our values and what this country can build together, few achievements rival the Trans Canada Trail: a 30,000-kilometre network stitched together over three...

GlobeNewswire, Inc.

Toronto, ON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nox Peptides has announced an expanded focus on research-use peptide compounds in Canada, highlighting BPC-157 and GHK-Cu as part of its ongoing efforts to support laboratory and preclinical research...

EIN Presswire

JAFFRAY, BRITISH COLUMBIA, CANADA, October 1, 2026 /⁨EINPresswire.com⁩/ -- There are people who enter our lives carrying a light that seems to shine even more brightly because of everything they have endured.

GlobeNewswire, Inc.

-- Favorable safety and tolerability profile maintained through up to 60 weeks of treatment with ontunisertib in Fibrostenosing Crohn’s disease (FSCD) patients -- -- Low annualized FSCD-related event rate of 3%, with one endoscopic balloon...